Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy

The association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinic...

Full description

Bibliographic Details
Main Authors: Xiaohao Zheng, Yunzi Wu, Li Zheng, Liyan Xue, Zhichao Jiang, Chenfeng Wang, Yibin Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671474/full
id doaj-95f4b216128a416a818608f635799f55
record_format Article
spelling doaj-95f4b216128a416a818608f635799f552021-07-26T12:49:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-07-011110.3389/fonc.2021.671474671474Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 GastrectomyXiaohao Zheng0Yunzi Wu1Li Zheng2Liyan Xue3Zhichao Jiang4Chenfeng Wang5Yibin Xie6Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of General Surgery, The First People’s Hospital of Dongcheng District, Beijing, ChinaDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaThe association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinical, and pathological information of 247 stage II gastric cancer patients who underwent radical D2 gastrectomy in our department between January 2011 and December 2014 were collected and retrospectively analyzed. The relationship between and long-term clinical outcomes of stage II gastric cancer was analyzed using t-tests, chi-square tests, receiver operating characteristic (ROC) analysis, time-dependent ROC analysis, K–M curves, and a Cox regression model. The median follow-up of 247 stage II gastric cancer patients was 5.49 years (range: 0.12–8.62 years). The Kaplan–Meier estimated 3-year and 5-year DSS rates of the study group were 92.7% (95% CI 89.4–95.9) and 88.7% (95% CI 84.7–92.7), respectively. Higher age (>70 vs. ≤70, log-rank p = 0.0406), nerve invasion (positive vs. negative, log-rank p = 0.0133), and non-distal gastrectomy (distal partial gastrectomy vs. other surgical methods, log-rank p = 0.00235) had worse prognoses compared to controls. Univariate and multivariate analyses of disease-specific survival showed that these three factors were independent prognostic factors for patients with stage II disease. The area under time-dependent ROC curve (AUC) is 0.748 of 5-year survival and c-index is 0.696 based on the three-marker model drawn for stage II patients. Subgroup analyses showed an interaction between tumor location and nerve invasion. The age, perineural invasion, and surgical approach are independent prognostic factors for disease-specific survival after radical gastrectomy. Tumor location may be an important confounding factor for outcomes by affecting surgical methods and the hazards of nerve invasion.https://www.frontiersin.org/articles/10.3389/fonc.2021.671474/fullgastric cancerdisease-specific survivalprognosisperineural invasiondistal gastrectomystage II
collection DOAJ
language English
format Article
sources DOAJ
author Xiaohao Zheng
Yunzi Wu
Li Zheng
Liyan Xue
Zhichao Jiang
Chenfeng Wang
Yibin Xie
spellingShingle Xiaohao Zheng
Yunzi Wu
Li Zheng
Liyan Xue
Zhichao Jiang
Chenfeng Wang
Yibin Xie
Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
Frontiers in Oncology
gastric cancer
disease-specific survival
prognosis
perineural invasion
distal gastrectomy
stage II
author_facet Xiaohao Zheng
Yunzi Wu
Li Zheng
Liyan Xue
Zhichao Jiang
Chenfeng Wang
Yibin Xie
author_sort Xiaohao Zheng
title Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_short Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_full Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_fullStr Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_full_unstemmed Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
title_sort disease-specific survival of ajcc 8th stage ii gastric cancer patients after d2 gastrectomy
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-07-01
description The association between the risk factors and long-term prognosis in patients with stage II gastric cancer after radical gastrectomy has been fully revealed. The purpose of this study was to investigate the independent risk factors for treatment failure in stage II gastric cancer. Demographic, clinical, and pathological information of 247 stage II gastric cancer patients who underwent radical D2 gastrectomy in our department between January 2011 and December 2014 were collected and retrospectively analyzed. The relationship between and long-term clinical outcomes of stage II gastric cancer was analyzed using t-tests, chi-square tests, receiver operating characteristic (ROC) analysis, time-dependent ROC analysis, K–M curves, and a Cox regression model. The median follow-up of 247 stage II gastric cancer patients was 5.49 years (range: 0.12–8.62 years). The Kaplan–Meier estimated 3-year and 5-year DSS rates of the study group were 92.7% (95% CI 89.4–95.9) and 88.7% (95% CI 84.7–92.7), respectively. Higher age (>70 vs. ≤70, log-rank p = 0.0406), nerve invasion (positive vs. negative, log-rank p = 0.0133), and non-distal gastrectomy (distal partial gastrectomy vs. other surgical methods, log-rank p = 0.00235) had worse prognoses compared to controls. Univariate and multivariate analyses of disease-specific survival showed that these three factors were independent prognostic factors for patients with stage II disease. The area under time-dependent ROC curve (AUC) is 0.748 of 5-year survival and c-index is 0.696 based on the three-marker model drawn for stage II patients. Subgroup analyses showed an interaction between tumor location and nerve invasion. The age, perineural invasion, and surgical approach are independent prognostic factors for disease-specific survival after radical gastrectomy. Tumor location may be an important confounding factor for outcomes by affecting surgical methods and the hazards of nerve invasion.
topic gastric cancer
disease-specific survival
prognosis
perineural invasion
distal gastrectomy
stage II
url https://www.frontiersin.org/articles/10.3389/fonc.2021.671474/full
work_keys_str_mv AT xiaohaozheng diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT yunziwu diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT lizheng diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT liyanxue diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT zhichaojiang diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT chenfengwang diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
AT yibinxie diseasespecificsurvivalofajcc8thstageiigastriccancerpatientsafterd2gastrectomy
_version_ 1721281321131573248